ALPN
Alpine Immune Sciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website alpineimmunesciences.com
- Employees(FY) 126
- ISIN US02083G1004
Performance
+0.51%
1W
+0.93%
1M
+123.03%
3M
+443.23%
6M
+240.87%
YTD
+649.37%
1Y
Profile
Alpine Immune Sciences, Inc. operates as a clinical-stage immunotherapy company. It focuses on creating various immunotherapies through protein engineering technologies for autoimmune and inflammatory diseases. The company has strategic collaborations with biopharmaceutical companies and has a pipeline of clinical and preclinical candidates in development. Its pipeline includes Povetacicept, a dual B cell cytokine antagonist for multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways for treatment of severe inflammatory diseases. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
Investment Analysis Report: ALPN
Overview
ALPN is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $2.05 billion. In this report, we will conduct a comprehensive analysis of ALPN's financial statements over the past three years, including the balance sheet...
Technical Analysis of ALPN 2024-05-10
Overview:
In analyzing the technical indicators for ALPN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide investme...
Recent News & Updates
- 2024-04-10 21:47
- 2024-04-10 19:34
5 Things to Know Before the Stock Market Opens(Investopedia)
- 2024-04-10 17:47
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion(The Wall Street Journal)
- 2024-04-10 17:14
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal(Investor's Business Daily)
- 2024-04-10 16:19
- 2024-04-10 16:16
- 2024-04-10 16:15
- 2024-04-10 16:06
- 2024-04-10 10:34
- 2024-04-10 07:05
- 2024-04-10 04:15
- 2024-04-10 04:01
- 2024-04-10 01:34
Vertex to buy kidney disease drugmaker Alpine for $4.9B(Yahoo Finance)
- 2024-04-09 09:23
- 2024-04-08 21:23
- 2024-04-01 09:00
- 2024-03-31 21:00
- 2024-03-28 07:08
- 2024-03-21 07:45
- 2024-03-20 19:45
- 2024-03-20 16:30
- 2024-03-20 07:27
- 2024-03-20 04:30
- 2024-03-19 08:32
- 2024-03-19 06:48
Q4 2023 Alpine Immune Sciences Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-03-18 20:32
- 2024-03-18 19:25
- 2024-03-18 17:31
- 2024-03-18 16:05
- 2024-03-18 08:53